Skip to main content
Search
Main content
JAMA
Published

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis

Authors

Ganna Blazhenets, David N Soleimani-Meigooni, Konstantinos Chiotis, Isabel E Allen, Gil D Rabinovici, Renaud La Joie, Meta-Centiloid Study Group, Liana G Apostolova, Breton M Asken, Alexandre Bejanin, Tammie L S Benzinger, Tobey J Betthauser, Marina Bluma, Stephanie Bombois, Pierrick Bourgeat, Vincent Bouteloup, Meredith N Braskie, Matthias Brendel, Adam M Brickman, Natalie Bryant, Santiago Bullich, Maria C Carrillo, Kaitlin Casaletto, David M Cash, Chiung-Chih Chang, Hsin-I Chang, Yishu Chao, Genevieve Chêne, Gaël Chételat, William Coath, Lyduine E Collij, Lise Colmant, Maria M Corrada, Suzanne Craft, Bradford C Dickerson, Bruno Dubois, Carole Dufouil, Alfonso Fajardo, Gill Farrar, Juan Fortea, Lars Frings, Giovanni B Frisoni, Raquel C Gardner, Valentina Garibotto, Johannes S Gnörich, Brian A Gordon, Yuna Gu, Yihui Guan, Tengfei Guo, Bernard J Hanseeuw, Oskar Hansson, Theresa M Harrison, Qi Huang, Shu-Hua Huang, Leonardo Iaccarino, Kazunari Ishii, Kenji Ishi, William J Jagust, Sterling C Johnson, Takashi Kato, Yuta Katsumi, Jeffrey Kaye, Robert A Koeppe, Guilherme D Kolinger, Joel H Kramer, Susan M Landau, Brigitte Landeau, Patrick J Lao, Sangwon Lee, Alberto Lleó, Brian J Lopresti, Val J Lowe, Jose A Luchsinger, Maura Malpetti, Xiaoxie Mao, Andrew March, Colin L Masters, Philipp T Meyer, Florence Mezenge, Elizabeth C Mormino, Maria Franquesa-Mullerat, Akinori Nakamura, Agneta Nordberg, John T O'Brien, Sid E O'Bryant, Ioannis Pappas, Debora E Peretti, Lisa Quenon, Christopher C Rowe, James B Rowe, Marc D Rudolph, Gemma Salvadó, Jonathan M Schott, Daniel L Schwartz, Christopher G Schwarz, Sang Won Seo, Mahnaz Shekari, Lisa C Silbert, Ruben Smith, Heather M Snyder, Andrzej Sokolowski, Reisa A Sperling, Pan Sun, Jacinda Z Taggett, Arthur W Toga, Alexandra Touroutoglou, David E Vaillancourt, Elsmarieke van de Giessen, Jort Vijverberg, Prashanthi Vemuri, Nicolas Villain, Victor L Villemagne, Sylvia Villeneuve, Wei-En Wang, Michael Weiner, Davis Woodworth, Cally Xiao, Fang Xie, Yeojun Yoon, Christina B Young, Mijin Yun, A4, ABIDE, ADNI*, ADNI-DoD, AgeWell, AIBL, AMYPAD, BACS, BATON, BIOCARD, BLSA, BioFINDER-2, BrANCH, CPAS, DETECT-AD, GEMS, GHABS, HABS, HABS-HD, IDEAS, IMAP, INSIGHT-preAD, Insight46, K-ROAD, LEADS, MCSA, MULNIAD, MEMENTO, SCAN, PREVENT-AD, SPIN, Severanc

Abstract

JAMA. 2026 Jul 13. doi: 10.1001/jama.2026.13116. Online ahead of print.

ABSTRACT

IMPORTANCE: Amyloid positron emission tomography (PET) is increasingly used in research and clinical settings to determine the etiology of cognitive decline and eligibility for amyloid-targeting therapies. To assist with amyloid PET evaluation and to guide clinical decision-making, images can be quantified in a standardized unit called Centiloid, the interpretation of which can vary according to the method and threshold used.

OBJECTIVE: To collect Centiloid values from available studies and determine robust positivity cutoffs using data-driven methods and correspondence with visual reads.

DATA SOURCES: PubMed search (October 2024) identified studies with Centiloid values. Corresponding authors were invited to share individual participant data. Additional data were obtained through access-controlled repositories and conference outreach (July 2024-July 2025).

STUDY SELECTION: Studies were included if they provided Centiloids, radiotracer, age, and sex.

DATA EXTRACTION AND SYNTHESIS: Each study was analyzed using a unified statistical pipeline; study estimates were pooled using random-effects meta-analysis.

MAIN OUTCOMES AND MEASURES: Gaussian mixture models (GMMs) were fitted to Centiloid values for each study. In studies with a bimodal distribution (per integrated completed likelihood), single cutoffs for positivity were set as mean plus 2 SDs of the lower gaussian component. Using GMMs, a double-cutoff approach defined a lower certainty range using a 90% posterior probability cutoff for assignment to the low (amyloid-negative) vs high (amyloid-positive) component. An alternative Centiloid cutoff was derived from maximizing the correspondence (Cohen κ) with the binary visual reads when available.

RESULTS: This meta-analysis included cross-sectional amyloid PET scans acquired with 5 radiotracers from 49 227 participants across 53 studies from 15 countries (mean age, 71 years; 54% female, 62% cognitively impaired). The data-driven GMM approach identified a bimodal distribution in 51 studies (n = 48 786), resulting in a single cutoff for positivity of 18 Centiloids (95% CI,16-19; I2 = 97%). The double-cutoff approach revealed high confidence for interpreting scans as negative when Centiloid values were lower than 11 (95% CI, 9-13; I2 = 95%) and interpreting scans as positive if Centiloid values were higher than 26 (95% CI, 24-28; I2 = 95%). In analyses of correspondence with binary (positive or negative) visual reads of amyloid PET scans (n = 35 045; 36 studies), Centiloids were highly predictive of visual positivity (Cohen κ, 0.86; 95% CI, 0.83-0.89; I2 = 96%) with a cutoff of 27 Centiloids (95% CI, 24-30; I2 = 80%).

CONCLUSIONS AND RELEVANCE: In this individual participant data meta-analysis, positivity cutoffs converged around 18 Centiloids (data-driven) and 27 Centiloids (visual reads). Findings from a double-cutoff analysis suggest that scans in the 11 to 26 Centiloid range should be interpreted with caution depending on the context of use.

PMID:42441390 | DOI:10.1001/jama.2026.13116

UK DRI Authors

Dr Maura Malpetti

Emerging Leader

Using specialist brain scans and novel blood tests to measure inflammation and accelerate the development of new treatments

Dr Maura Malpetti